Skip to Main Content

Paper Details

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy.
J Immunother Cancer
19
2022
Author NameAffiliation
Min LuoInstitute of Pediatrics, Children's Hospital of Fudan University, Institutes of Biomedical Sciences, Fudan University
  • 1 - 1

Datasets

Release 1.2